Novartis has settled a suit by Henrietta Lacks' estate alleging the pharmaceutical giant unjustly profited off cells were ...

Researchers hope to undertake clinical studies in multiple cancers, including ovarian cancer, glioblastoma, and others.

A proof-of-concept study opens up an avenue for treating solid tumours that express low levels of a target antigen.

Doctors at Johns Hopkins Hospital took Henrietta Lacks’ cervical cells in 1951 without her knowledge. Those HeLa cells became ...

It's widely known that breastfeeding impacts the health of both mother and child, but the underlying biology that leads to ...

Though CAR T cells have been effective against certain blood cancers, they have not been for solid tumors. Now, a new form of ...

In 2024, Professor Sebastian Kobold's research group at LMU University Hospital had already shown that the metabolite ...

Attorneys for the family have indicated there could be additional complaints filed ...

Northwestern researchers have shown that when it comes to cancer vaccines, arrangement can be just as important as ingredients. By repositioning a small fragment of an HPV protein on a DNA-based ...

It’s the second settlement in lawsuits filed by the estate that accused biomedical businesses of reaping rewards from a ...

Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells ...